ImmunityBio (IBRX) Short-term Investments (2015 - 2026)
ImmunityBio (IBRX) posted Short-term Investments of $281.7 million for Q2 2026, compared with $16 million a year earlier and up 60.3% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Short-term Investments (2015 - 2026) Analysis & Trends
At the end of FY2025, ImmunityBio's Short-term Investments came in at $154.48 million.
- Annual Short-term Investments shows a five-year compound annual growth rate of 20.4% (FY2020 to FY2025).
- In prior years, ImmunityBio's Short-term Investments was $6.38 million in FY2024 (+532.4%), $1.01 million in FY2023 (-60.3%), $2.54 million in FY2022 (-98.1%) and $136.02 million in FY2021 (+122.4%).
- The Q2 2026 figure stands as the highest quarterly Short-term Investments in data going back to Q4 2015.
- On a year-over-year basis, Short-term Investments increased in three of the last five quarters, with growth averaging 276.5%.
- The strongest year-over-year quarter for Short-term Investments in the past five years was Q3 2025, with growth of 973.7%; the weakest was Q1 2023, with a decline of 98.2%.
- According to Business Quant data, Short-term Investments for the three prior quarters was $175.69 million (Q1 2026), $154.48 million (Q4 2025) and $197.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | ImmunityBio | 9.94 Bn | 8.70 Bn | 50.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 281.70 Mn |
| Mar 31, 2026 | 175.69 Mn |
| Dec 31, 2025 | 154.48 Mn |
| Sep 30, 2025 | 197.57 Mn |
| Jun 30, 2025 | 16.00 Mn |
| Mar 31, 2025 | 931,000.00 |
| Dec 31, 2024 | 6.38 Mn |
| Sep 30, 2024 | 18.40 Mn |
| Jun 30, 2024 | 87.88 Mn |
| Mar 31, 2024 | 37.46 Mn |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | 11.83 Mn |
| Jun 30, 2023 | 2.45 Mn |
| Mar 31, 2023 | 2.79 Mn |
| Dec 31, 2022 | 2.54 Mn |
| Sep 30, 2022 | 6.90 Mn |
| Jun 30, 2022 | 21.04 Mn |
| Mar 31, 2022 | 155.95 Mn |
| Dec 31, 2021 | 136.02 Mn |
| Sep 30, 2021 | 15.85 Mn |
API Access
ImmunityBio Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();